Executive Order 13676 established the Federal Task Force for Combating Antibiotic-Resistant Bacteria (CARB) to identify actions to implement the National Strategy.
View the CARB Task Force 2-pager for more information.
The Department of Health and Human Services (HHS) and its following components:
AHRQ - Agency for Healthcare Research and Quality
ASPE - Office of the Assistant Secretary for Planning and Evaluation
ASPR - Administration for Strategic Preparedness and Response
BARDA - Biomedical Advanced Research and Development Authority within ASPR
CDC - Centers for Disease Control and Prevention
CMS - Centers for Medicare & Medicaid Services
FDA - Food and Drug Administration
NIH - National Institutes of Health
OGA - Office of Global Affairs
The United States Department of Agriculture (USDA) and its following components:
APHIS - Animal and Plant Health Inspection Service
ARS - Agricultural Research Service
FAS - Foreign Agricultural Service
FSIS - Food Safety and Inspection Service
NIFA - National Institute of Food and Agriculture
OCS - Office of the Chief Scientist
The Department of Defense (DoD) and its following components:
DHA - Defense Health Agency
GEIS - Global Emerging Infections Surveillance
IDCRP - Infectious Disease Clinical Research Program
MIDRP - Military Infectious Diseases Research Program
MRSN - Multidrug-Resistant Organism Repository and Surveillance Network
PVC - Pharmacovigilance Center
WRAIR - Walter Reed Army Institute of Research
The Department of the Interior (DoI)
The Department of State (DoS)
The Environmental Protection Agency (EPA)
The United States Agency for International Development (USAID)
The Department of Veterans Affairs (VA)
The Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB), also established by Executive Order 13676, is composed of both Federal and non-Federal subject-matter experts in human and agricultural health. The PACCARB provides information and recommendations to the HHS Secretary regarding programs and policies to combat antibiotic resistance and to improve capabilities to prevent, diagnose, mitigate, or treat antibiotic-resistant infections.